WIV website lists international partnership

 5-29-21   The WIV website also lists international partnership with EcoHealth Alliance of USA; INSERM and Lyon P4 Laboratory of France; Biological Research Center, Defense Science and Technology Organization, Pakistan; International Centre for Chemical and Biological Sciences, University of Karachi, etc.

Prominent on the list of more than 100 researchers of the WIV is Ashaq Ali, a researcher from University of Lahore, who is investigating “emerging viruses and other highly infectious pathogens”, as mentioned by him on a research website.  WIV has also had close ties with the Galveston National Laboratory in the United States, the Centre International de Recherche en Infectiologie in France, and the National Microbiology Laboratory in Canada.  jointly authored by 15 researchers including Ralph S. Basic’s team at University of North Carolina; Xing-Yi Ge and Zhengli-Li Shi from Key Laboratory of “Special Pathogens and Biosafety, WIV”; and labs in Boston and Zurich. They showed that a lab-generated chimeric virus caused severe disease in  the lungs of humanized mice and that such mice cannot be protected with then existing therapeutic neutralizing antibodies developed against SARS-CoV. The authors also noted that “On the basis of these findings, scientific review panels may deem similar studies building chimeric viruses based on circulating strains too risky to pursue, as increased pathogenicity in mammalian models cannot be excluded.  Together, these data and restrictions represent a crossroads of GOF research concerns; the potential to prepare for and mitigate future outbreaks must be weighed against the risk of creating more dangerous pathogens.” They acknowledged grants from the US National Institutes of Health (NIH) and that the “Human airway epithelial cultures” were supported by the National Institute of Diabetes and Digestive and Kidney Disease of the NIH. Another article on SARS coronavirus published on 30 November 2017 in the journal PLOS Pathogens by Ben Hu and associates from WIV acknowledged funding from multiple sources including USAID Emerging Pandemic Threats (EPT) and the Strategic Priority Research Program of the Chinese Academy of Sciences.

it is obvious that gain of function research on emerging pandemic threats i.e., corona and influenza viruses was done using humanized mice and human airway epithelial cultures, and deadly chimeric viruses were produced even before the BSL4 facility was set up.  They have also acknowledged their collaborators and those who were funding them.  Investigation into the US intelligence report that many (some) of WIV researchers became sick in autumn 2019 with symptoms consistent with Covid-19 should reveal the truth about the outbreak.   https://www.sundayguardianlive.com/news/wuhan-institute-virology-prime-suspect-sars2-pandemic

……………………………………….